vs
JOINT Corp（JYNT）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是JOINT Corp的1.3倍（$19.6M vs $15.2M），JOINT Corp净利率更高（6.5% vs -177.4%，领先183.9%），JOINT Corp同比增速更快（3.1% vs -11.5%），JOINT Corp自由现金流更多（$334.7K vs $-23.1M），过去两年STANDARD BIOTOOLS INC.的营收复合增速更高（-12.2% vs -28.6%）
JOINT Corp是美国领先的脊椎按摩护理诊所运营方与特许经营商，主打高性价比的脊椎护理服务，推出会员制护理方案，面向寻求非侵入式肌肉骨骼疼痛管理及日常健康调理的消费者。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
JYNT vs LAB — 直观对比
营收规模更大
LAB
是对方的1.3倍
$15.2M
营收增速更快
JYNT
高出14.6%
-11.5%
净利率更高
JYNT
高出183.9%
-177.4%
自由现金流更多
JYNT
多$23.4M
$-23.1M
两年增速更快
LAB
近两年复合增速
-28.6%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $15.2M | $19.6M |
| 净利润 | $991.1K | $-34.7M |
| 毛利率 | 81.4% | 48.5% |
| 营业利润率 | 4.9% | -168.5% |
| 净利率 | 6.5% | -177.4% |
| 营收同比 | 3.1% | -11.5% |
| 净利润同比 | 5510.5% | -28.8% |
| 每股收益（稀释后） | $0.06 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收JYNTLAB
| Q4 25 | $15.2M | — | ||
| Q3 25 | $13.4M | $19.6M | ||
| Q2 25 | $13.3M | $21.8M | ||
| Q1 25 | $13.1M | $40.8M | ||
| Q4 24 | $14.7M | — | ||
| Q3 24 | $30.2M | $22.1M | ||
| Q2 24 | $30.3M | $22.5M | ||
| Q1 24 | $29.7M | $45.5M |
净利润JYNTLAB
| Q4 25 | $991.1K | — | ||
| Q3 25 | $855.0K | $-34.7M | ||
| Q2 25 | $93.4K | $-33.5M | ||
| Q1 25 | $967.8K | $-26.0M | ||
| Q4 24 | $17.7K | — | ||
| Q3 24 | $-3.2M | $-26.9M | ||
| Q2 24 | $-3.6M | $-45.7M | ||
| Q1 24 | $947.0K | $-32.2M |
毛利率JYNTLAB
| Q4 25 | 81.4% | — | ||
| Q3 25 | 80.1% | 48.5% | ||
| Q2 25 | 79.1% | 48.8% | ||
| Q1 25 | 77.3% | 48.4% | ||
| Q4 24 | 78.4% | — | ||
| Q3 24 | 90.7% | 54.9% | ||
| Q2 24 | 90.7% | 46.1% | ||
| Q1 24 | 90.9% | 53.1% |
营业利润率JYNTLAB
| Q4 25 | 4.9% | — | ||
| Q3 25 | 1.2% | -168.5% | ||
| Q2 25 | -8.6% | -118.1% | ||
| Q1 25 | -5.2% | -80.8% | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | -1.6% | -120.9% | ||
| Q2 24 | -5.9% | -134.5% | ||
| Q1 24 | -1.4% | -132.2% |
净利率JYNTLAB
| Q4 25 | 6.5% | — | ||
| Q3 25 | 6.4% | -177.4% | ||
| Q2 25 | 0.7% | -153.7% | ||
| Q1 25 | 7.4% | -63.8% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | -10.5% | -122.0% | ||
| Q2 24 | -11.9% | -203.3% | ||
| Q1 24 | 3.2% | -70.6% |
每股收益（稀释后）JYNTLAB
| Q4 25 | $0.06 | — | ||
| Q3 25 | $0.06 | $-0.09 | ||
| Q2 25 | $0.01 | $-0.09 | ||
| Q1 25 | $0.06 | $-0.07 | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $-0.21 | $-0.07 | ||
| Q2 24 | $-0.24 | $-0.12 | ||
| Q1 24 | $0.06 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.6M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $15.1M | $399.7M |
| 总资产 | $61.0M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资JYNTLAB
| Q4 25 | $23.6M | — | ||
| Q3 25 | $29.7M | $129.4M | ||
| Q2 25 | $29.8M | $158.6M | ||
| Q1 25 | $21.9M | $150.9M | ||
| Q4 24 | $25.1M | — | ||
| Q3 24 | $20.7M | $210.6M | ||
| Q2 24 | $17.5M | $269.8M | ||
| Q1 24 | $18.7M | $287.1M |
总债务JYNTLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益JYNTLAB
| Q4 25 | $15.1M | — | ||
| Q3 25 | $22.7M | $399.7M | ||
| Q2 25 | $23.2M | $424.5M | ||
| Q1 25 | $22.8M | $454.6M | ||
| Q4 24 | $20.7M | — | ||
| Q3 24 | $20.5M | $489.3M | ||
| Q2 24 | $23.2M | $510.3M | ||
| Q1 24 | $26.2M | $577.3M |
总资产JYNTLAB
| Q4 25 | $61.0M | — | ||
| Q3 25 | $69.4M | $539.6M | ||
| Q2 25 | $73.2M | $557.0M | ||
| Q1 25 | $80.1M | $579.6M | ||
| Q4 24 | $83.2M | — | ||
| Q3 24 | $79.6M | $681.5M | ||
| Q2 24 | $82.4M | $708.7M | ||
| Q1 24 | $85.7M | $777.7M |
负债/权益比JYNTLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.8M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $334.7K | $-23.1M |
| 自由现金流率自由现金流/营收 | 2.2% | -118.1% |
| 资本支出强度资本支出/营收 | 9.9% | 4.5% |
| 现金转化率经营现金流/净利润 | 1.86× | — |
| 过去12个月自由现金流最近4个季度 | $-1.9M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流JYNTLAB
| Q4 25 | $1.8M | — | ||
| Q3 25 | $1.8M | $-22.2M | ||
| Q2 25 | $868.6K | $-20.7M | ||
| Q1 25 | $-3.7M | $-30.3M | ||
| Q4 24 | $9.4M | — | ||
| Q3 24 | $3.4M | $-27.9M | ||
| Q2 24 | $-973.5K | $-39.0M | ||
| Q1 24 | $2.8M | $-62.5M |
自由现金流JYNTLAB
| Q4 25 | $334.7K | — | ||
| Q3 25 | $1.5M | $-23.1M | ||
| Q2 25 | $363.6K | $-22.6M | ||
| Q1 25 | $-4.0M | $-35.3M | ||
| Q4 24 | $8.2M | — | ||
| Q3 24 | $3.2M | $-30.1M | ||
| Q2 24 | $-1.2M | $-41.0M | ||
| Q1 24 | $2.4M | $-63.3M |
自由现金流率JYNTLAB
| Q4 25 | 2.2% | — | ||
| Q3 25 | 10.9% | -118.1% | ||
| Q2 25 | 2.7% | -103.6% | ||
| Q1 25 | -30.8% | -86.6% | ||
| Q4 24 | 55.9% | — | ||
| Q3 24 | 10.6% | -136.4% | ||
| Q2 24 | -4.1% | -182.2% | ||
| Q1 24 | 8.1% | -138.9% |
资本支出强度JYNTLAB
| Q4 25 | 9.9% | — | ||
| Q3 25 | 2.4% | 4.5% | ||
| Q2 25 | 3.8% | 8.7% | ||
| Q1 25 | 2.5% | 12.4% | ||
| Q4 24 | 8.1% | — | ||
| Q3 24 | 0.8% | 10.2% | ||
| Q2 24 | 0.9% | 8.6% | ||
| Q1 24 | 1.3% | 1.7% |
现金转化率JYNTLAB
| Q4 25 | 1.86× | — | ||
| Q3 25 | 2.07× | — | ||
| Q2 25 | 9.30× | — | ||
| Q1 25 | -3.82× | — | ||
| Q4 24 | 532.98× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
JYNT
| Transferred At Point In Time | $12.8M | 84% |
| Transferred Over Time | $2.4M | 16% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
